Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing clorquinaldol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clorquinaldol |
Inferred relationship |
Some |
|
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clorquinaldol |
Inferred relationship |
Some |
|
Product containing clorquinaldol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clorquinaldol |
Inferred relationship |
Some |
2 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Clorquinaldol |
Inferred relationship |
Some |
2 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Product containing clorquinaldol and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Product containing only clorquinaldol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Product containing only clorquinaldol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Clorquinaldol and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clorquinaldol |
Inferred relationship |
Some |
1 |